Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Recent news has taken most........................
View:
Post by ggrellette on Sep 01, 2022 12:07pm

Recent news has taken most........................

shareholders by surprise. That lack by the company to put out a press release just about her says she over stayed her welcome which is very un-nerving to say the least especially ALL the fanfare that this company prodcasted when she was joining the team. Something here is definitely afoot and it is rotten IMHO. The news was hidden in the financials that were released and that is NEVER a good sign. By doing that the company does not want to advertise her departure but has to by LAW.
Comment by jmm1228 on Sep 01, 2022 12:34pm
My take is that the culture change may have been an issue. Dr. V had been a big fish in abpowerhoue firm. The transition to TLT was huge for her (and TLT), obviously it did not work. In the end it is the science that will pull TLT through, despite personnel and financial woes. Seems to me a Grant is warranted - government or private, as the science is proving itself, alas at an aggravating pace, ...more  
Comment by Rumpl3StiltSkin on Sep 01, 2022 1:17pm
I agree with all of this, I do think 90 days from now the TR numbers will look a ton better. I believe TLT has plenty of money to get to that timeframe.  They may have had to Let Dr. Vera go because the money is soo tight.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250